Nicotinamide adenine dinucleotide, a coenzyme critical for cellular energy metabolism that declines with age. NAD+ precursors like NMN and NR are studied as longevity interventions.

Mechanistic target of rapamycin, a key nutrient-sensing pathway that regulates cell growth and aging. Inhibiting mTOR (e.g., with rapamycin) has shown lifespan extension in multiple organisms.

A class of drugs that selectively eliminate senescent (aged, dysfunctional) cells to reduce inflammation and improve tissue function.

What is Epigenetic clock?

A biomarker based on DNA methylation patterns that estimates biological age, often more predictive of health outcomes than chronological age.

The period of life spent in good health, free from chronic diseases and disability associated with aging.

An immunosuppressant drug that inhibits the mTOR pathway. Research shows rapamycin may extend lifespan and improve age-related health outcomes in multiple species.

What is Biological age?

A measure of how well or poorly your body is functioning relative to your chronological age, assessed through biomarkers such as DNA methylation, telomere length, and blood panels.

What is Caloric restriction?

A dietary regimen that reduces calorie intake without malnutrition. Caloric restriction is one of the most studied interventions shown to extend lifespan across species.

Protective caps at the ends of chromosomes that shorten with each cell division. Telomere length is associated with aging and age-related diseases.

A state in which cells permanently stop dividing but resist death, accumulating with age and secreting inflammatory factors that damage surrounding tissue.

A second-generation epigenetic clock that predicts time to death and is considered one of the most accurate measures of biological aging.

What is Inflammaging?

Chronic, low-grade inflammation that increases with age and contributes to the development of age-related diseases including cardiovascular disease, diabetes, and neurodegeneration.

The large-scale study of proteins in biological systems. In longevity research, proteomics identifies blood protein signatures that predict biological age and disease risk.

What is Yamanaka factors?

A set of four transcription factors (Oct4, Sox2, Klf4, c-Myc) that can reprogram adult cells to a pluripotent state. Partial reprogramming with Yamanaka factors is being explored to reverse cellular aging.

Nicotinamide mononucleotide, a precursor to NAD+ that is widely studied as a supplement to boost cellular energy and combat age-related decline.

A gene-editing technology that allows precise modifications to DNA. In longevity research, CRISPR is used to study and potentially modify genes associated with aging.

Blue Mountain Acquires CompuCal to Expand European Presence and Deepen Calibration Expertise

Blue Mountain has announced the acquisition of CompuCal Calibration Solutions, enhancing its position in the European life sciences sector. This strategic move follows a recent investment from Five Arrows, aimed at expanding Blue Mountain’s global footprint and capabilities in Enterprise Asset Management (EAM) for regulated industries. CompuCal’s established expertise in calibration and maintenance management, particularly in highly regulated environments, complements Blue Mountain’s existing offerings and strengthens its service delivery across key European markets, including the UK, Ireland, DACH, and Nordic regions.

The acquisition is significant as it integrates CompuCal’s specialized knowledge and proven regulatory compliance into Blue Mountain’s operations. With decades of experience in calibration workflows, CompuCal brings a robust customer base and localized implementation capabilities that are essential for supporting the full lifecycle of regulated assets. This enhancement is expected to improve operational efficiency and compliance for life sciences manufacturers, which are increasingly under pressure to meet stringent regulatory standards. Blue Mountain’s CEO, David H. Rode, emphasized that this acquisition not only broadens their service capabilities but also aligns with their commitment to providing high-quality solutions tailored to customer needs in the life sciences sector.

This acquisition shifts the landscape for EAM solutions in the life sciences by combining advanced calibration expertise with comprehensive asset management. For researchers and professionals in aging biology and longevity science, this development may accelerate timelines for drug development and clinical trials by ensuring that the equipment used in research and production meets the highest standards of compliance and operational rigor. As regulatory environments become more complex, the integration of CompuCal’s capabilities could lead to more efficient pathways for bringing innovative therapies to market.

Source: globenewswire.com